Source:http://linkedlifedata.com/resource/pubmed/id/16734392
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
2006-5-31
|
| pubmed:abstractText |
Decreasing HRT use among postmenopausal women may have a reciprocal impact on other osteoporosis therapy. Time series analysis of prescribing trends for millions of Medicaid beneficiaries revealed a 57% decline in HRT without augmenting the pace of bisphosphonate use. Prescribing changes dramatically increased Medicaid spending on osteoporosis therapy over the last decade and requires further evaluation of cost effectiveness.
|
| pubmed:grant | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
May
|
| pubmed:issn |
0884-0431
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
765-71
|
| pubmed:dateRevised |
2007-11-14
|
| pubmed:meshHeading |
pubmed-meshheading:16734392-Calcitonin,
pubmed-meshheading:16734392-Calcium,
pubmed-meshheading:16734392-Cost of Illness,
pubmed-meshheading:16734392-Diphosphonates,
pubmed-meshheading:16734392-Estrogen Replacement Therapy,
pubmed-meshheading:16734392-Female,
pubmed-meshheading:16734392-Humans,
pubmed-meshheading:16734392-Medicaid,
pubmed-meshheading:16734392-Osteoporosis,
pubmed-meshheading:16734392-Raloxifene,
pubmed-meshheading:16734392-United States,
pubmed-meshheading:16734392-Women's Health
|
| pubmed:year |
2006
|
| pubmed:articleTitle |
Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid.
|
| pubmed:affiliation |
Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|